NCT00566696 Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies Status COMPLETED Phase PHASE2
NCT00556452 Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen Status COMPLETED Phase PHASE1/PHASE2
NCT00543582 MGCD0103 Administered in Combination With Azacitidine (Vidaza®) to Subjects With Relapsed or Refractory Hodgkin or Non-Hodgkin Lymphoma Status TERMINATED Phase PHASE2
NCT00539695 Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD Status COMPLETED Phase PHASE2
NCT00439361 Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma Status COMPLETED Phase PHASE1
NCT00392314 Tailored Therapy for Hodgkin Lymphoma Using Early Interim Therapy PET for Therapy Decision. Status COMPLETED Phase PHASE2
NCT00301314 A Retrospective Study of Toxicity and Outcome of High Dose Chemotherapy With Autologous Stem Cell Transplant in Patients With Hodgkin Lymphoma (HL). Status COMPLETED Phase N/A
NCT00096161 Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant Status COMPLETED Phase PHASE2
NCT00013533 Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies Status COMPLETED Phase EARLY_PHASE1
NCT00002561 Radiation Therapy and Chemotherapy in Treating Patients With Hodgkin's Disease Status COMPLETED Phase PHASE3